Compounds > erythromycin

Page last updated: 2024-08-21

erythromycin and tegaserod

erythromycin has been researched along with tegaserod in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Drici, MD; Ebert, SN; Liu, XK; Rodriguez, I; Wang, WX; Whitfield, BH; Woosley, RL	1
Bassil, A; Corcoran, S; Jarvie, EM; North Laidler, VJ; Sanger, GJ	1
Bollegala, NP; Khanna, R; Leontiadis, GI; Moayyedi, P; Pittayanon, R; Yuan, Y	1

Reviews

2 review(s) available for erythromycin and tegaserod

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Prokinetics for functional dyspepsia. The Cochrane database of systematic reviews, 2018, Oct-18, Volume: 10 Topics: Benzamides; Benzyl Compounds; Cisapride; Domperidone; Dyspepsia; Erythromycin; Gastrointestinal Agents; Humans; Indoles; Morpholines; Numbers Needed To Treat; Quality of Life; Randomized Controlled Trials as Topic; Thiazoles	2018

Other Studies

5 other study(ies) available for erythromycin and tegaserod

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart. Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:1 Topics: Animals; Cisapride; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Female; Gastrointestinal Agents; Heart; In Vitro Techniques; Indoles; Perfusion; Rabbits	1999
Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. British journal of pharmacology, 2007, Volume: 150, Issue:4 Topics: Animals; Carbachol; Dose-Response Relationship, Drug; Electric Stimulation; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Half-Life; In Vitro Techniques; Indoles; Ligands; Male; Manometry; Motilin; Muscarinic Agonists; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Receptors, Serotonin, 5-HT4; Serotonin Receptor Agonists; Stimulation, Chemical	2007